[Journal logo]

Volume 67 
Part 1 
Pages m9-m10  
January 2011  

Received 23 November 2010
Accepted 28 November 2010
Online 4 December 2010

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.008 Å
R = 0.040
wR = 0.103
Data-to-parameter ratio = 18.5
Details
Open access

Bromidotricarbonyl[2-(pyridin-2-yl-[kappa]N)-5-p-tolyl-1,3,4-oxadiazole-[kappa]N3]rhenium(I) dichloromethane monosolvate

aCollege of Sciences, Zhejiang A&F University, Lin'an, Hangzhou, Zhejiang 311300, People's Republic of China,bSchool of Chemical Engineering & Technology, Harbin Institute of Technology, Harbin 150001, People's Republic of China, and cSchool of Materials Science and Engineering, Changchun University of Science and Technology, Changchun 130000, People's Republic of China
Correspondence e-mail: lfshi2003@163.com

In the title compound, [ReBr(C14H11N3O)(CO)3]·CH2Cl2, the coordination geometry of the ReI atom is a distorted ReC3N2Br octahedron with the carbonyl C atoms in a fac arrangement. Within the 2-(pyridin-2-yl)-5-p-tolyl-1,3,4-oxadiazole ligand, the dihedral angles between the oxadiazole ring and the pyridine (py) and benzene (bz) rings are 1.7 (2) and 7.1 (2)°, respectively, and the dihedral angle between the py and bz rings is 5.5 (2)°. In the crystal, aromatic [pi]-[pi] stacking between the oxadiazole rings of adjacent molecules [centroid-centroid separation = 3.465 (3) Å] is seen.

Related literature

For backgroud to phosphoresence in Re(I) complexes, see: Ley et al. (1997[Ley, K.-D., Whittle, C.-E., Bartberger, M.-D. & Schanze, K.-S. (1997). J. Am. Chem. Soc. 119, 3423-3424.]); Zhang et al. (2009[Zhang, L.-M., Li, B. & Su, Z.-M. (2009). Langmuir, 25, 2068-2074.]). For a related structure, see: Rajendran et al. (2000[Rajendran, T., Manimaran, B., Lee, F.-Y., Lee, G.-H., Peng, S.-M., Wang, C.-C. & Lu, K.-L. (2000). Inorg. Chem. 39, 2016-2017.]). For the synthesis of the ligand, see: Demko & Sharpless (2001[Demko, Z.-P. & Sharpless, K.-B. (2001). J. Org. Chem. 66, 7945-7950.]); Tamoto et al. (1997[Tamoto, N., Adachi, C. & Ngai, K. (1997). Chem. Mater. 9, 1077-1085.]).

[Scheme 1]

Experimental

Crystal data
  • [ReBr(C14H11N3O)(CO)3]·CH2Cl2

  • Mr = 672.32

  • Monoclinic, C 2/c

  • a = 12.590 (3) Å

  • b = 19.621 (4) Å

  • c = 17.660 (4) Å

  • [beta] = 101.77 (3)°

  • V = 4270.8 (15) Å3

  • Z = 8

  • Mo K[alpha] radiation

  • [mu] = 7.84 mm-1

  • T = 293 K

  • 0.25 × 0.22 × 0.11 mm

Data collection
  • Bruker SMART CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2002)[Bruker (2002). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.] Tmin = 0.149, Tmax = 0.409

  • 20653 measured reflections

  • 4847 independent reflections

  • 4254 reflections with I > 2[sigma](I)

  • Rint = 0.063

Refinement
  • R[F2 > 2[sigma](F2)] = 0.040

  • wR(F2) = 0.103

  • S = 1.05

  • 4847 reflections

  • 262 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 2.07 e Å-3

  • [Delta][rho]min = -2.88 e Å-3

Table 1
Selected bond lengths (Å)

Re1-C1 1.887 (6)
Re1-C2 1.921 (5)
Re1-C3 1.890 (5)
Re1-N1 2.228 (4)
Re1-N2 2.169 (4)
Re1-Br1 2.6146 (11)

Data collection: SMART (Bruker, 2002[Bruker (2002). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2002[Bruker (2002). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXL97.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HB5758 ).


Acknowledgements

This work was supported by Zhejiang A & F University Science Foundation (2009FR068).

References

Bruker (2002). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Demko, Z.-P. & Sharpless, K.-B. (2001). J. Org. Chem. 66, 7945-7950.  [CrossRef] [PubMed] [ChemPort]
Ley, K.-D., Whittle, C.-E., Bartberger, M.-D. & Schanze, K.-S. (1997). J. Am. Chem. Soc. 119, 3423-3424.  [CrossRef] [ChemPort] [ISI]
Rajendran, T., Manimaran, B., Lee, F.-Y., Lee, G.-H., Peng, S.-M., Wang, C.-C. & Lu, K.-L. (2000). Inorg. Chem. 39, 2016-2017.  [ISI] [CrossRef] [PubMed] [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Tamoto, N., Adachi, C. & Ngai, K. (1997). Chem. Mater. 9, 1077-1085.  [CrossRef] [ChemPort] [ISI]
Zhang, L.-M., Li, B. & Su, Z.-M. (2009). Langmuir, 25, 2068-2074.  [ISI] [CrossRef] [PubMed]


Acta Cryst (2011). E67, m9-m10   [ doi:10.1107/S160053681004969X ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.